Treace Medical Concepts Inc (TMCI)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $345.50M
Last updated: Nov 17, 2026 at 4:10 PM ET
Treace Medical Concepts Inc (TMCI) Stock Chart
Treace Medical Concepts (TMCI) has a latest price of $4.44 on Nov 17, 2026, 18.4% below its 52-week high of $5.44. Its price rose 46.5% over the past 12 months. The month-end price fell 80.8% over the 5 years through Oct 2026, a compound annual decline of 28.1%.
Price Chart
From Apr 2021 to Oct 2026, its highest month-end close was $32.45 in May 2021 and its lowest $1.34 in Mar 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TMCI with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TMCI.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 2.6%, and over 6 months it rose 63.2%. The month-end price fell 55.8% over the 3 years through Oct 2026, a compound annual decline of 23.8%.
| Period | Change |
|---|---|
| 1 month | +14.4% |
| 3 months | -2.6% |
| 6 months | +63.2% |
| 12 months | +46.5% |
| 12 months, with dividends | +46.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -55.8% | -23.8% |
| 5 years | -80.8% | -28.1% |
Price by Year
Its best calendar year was 2022, when the price rose 23.3%, and its weakest was 2025, when it fell 67.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.43 | +80.8% |
| 2025 | $2.45 | -67.1% |
| 2024 | $7.44 | -41.6% |
| 2023 | $12.75 | -44.5% |
| 2022 | $22.99 | +23.3% |
Trading Range
The price is 0.5% above its 50-day average of $4.42 and 32.0% above its 200-day average of $3.36.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.44 | |
| 52-week high | $5.44 | -18.4% |
| 52-week low | $1.17 | +279.5% |
| 50-day average | $4.42 | +0.5% |
| 200-day average | $3.36 | +32.0% |
Price Risk
Over 3 years, its largest fall from a peak was 92.4%.
| Measure | Value |
|---|---|
| 1-year beta | 2.16 |
| Largest fall, 1 year | -61.2% |
| Largest fall, 3 years | -92.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TMCI
What is TMCI's 1-year price change?
Treace Medical Concepts's price rose 46.5% over the past 12 months. With dividends included, the 12-month total return was 46.5%.
What is TMCI's 5-year price change?
Treace Medical Concepts's month-end price fell 80.8% over the 5 years through Oct 2026, a compound annual decline of 28.1%. These figures leave out dividends.
What is TMCI's 52-week high and low?
Treace Medical Concepts's 52-week high is $5.44 and its 52-week low is $1.17. Its latest price of $4.44 on Nov 17, 2026 is 18.4% below the high.
What is TMCI's beta?
Treace Medical Concepts's 1-year beta against the S&P 500 is 2.16, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 61.2%.
Is the TMCI chart free?
Yes. Advanced Charting for TMCI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TMCI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts